1-16 of 16
Authors: Guangrong Lu
Save search
Sort by
Journal Article

Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy Open Access

PDF
Sharon L Gardner and others
Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac143, https://doi.org/10.1093/noajnl/vdac143
Published: 13 September 2022
Journal Article

SYST-14 CLINICAL EFFICACY OF ONC201 IN RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA (DMG) PATIENTS Open Access

PDF
Isabel Arrillaga-Romany and others
Neuro-Oncology Advances, Volume 4, Issue Supplement_1, August 2022, Page i24, https://doi.org/10.1093/noajnl/vdac078.093
Published: 05 August 2022
Journal Article

LTBK-05. CLINICAL EFFICACY OF ONC201 IN RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA PATIENTS Free

PDF
Isabel Arrillaga-Romany and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi230, https://doi.org/10.1093/neuonc/noab196.925
Published: 19 November 2021
Journal Article

CTNI-27. SINGLE AGENT ACTIVITY OF ONC201 IN NON-MIDLINE H3 K27M-MUTANT DIFFUSE GLIOMAS Free

PDF
Yazmin Odia and others
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi65, https://doi.org/10.1093/neuonc/noab196.252
Published: 12 November 2021
Journal Article

HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA Open Access

PDF
Abed Rahman Kawakibi and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii347, https://doi.org/10.1093/neuonc/noaa222.305
Published: 04 December 2020
Journal Article

DIPG-52. PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K27M-MUTANT GLIOMA OR NEWLY DIAGNOSED DIPG Open Access

PDF
Sharon Gardner and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii297, https://doi.org/10.1093/neuonc/noaa222.097
Published: 04 December 2020
Journal Article

NCMP-09. POSTMORTEM STUDY OF ORGAN SPECIFIC TOXICITY IN GLIOBLASTOMA PATIENTS TREATED WITH A COMBINATION OF TEMOZOLOMIDE, BEVACIZUMAB AND IRINOTECAN Free

PDF
Jay-Jiguang Zhu and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii124–ii125, https://doi.org/10.1093/neuonc/noaa215.521
Published: 09 November 2020
Journal Article

CTNI-15. CLINICAL EFFICACY OF ONC201 IN NEWLY DIAGNOSED DIPG AND IN PREVIOUSLY IRRADIATED PEDIATRIC H3 K27M-MUTANT GLIOMAS Free

PDF
Sharon Gardner and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii45, https://doi.org/10.1093/neuonc/noaa215.182
Published: 09 November 2020
Journal Article

CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA Free

PDF
Abed Rahman Kawakibi and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii45–ii46, https://doi.org/10.1093/neuonc/noaa215.184
Published: 09 November 2020
Journal Article

CTNI-37. EFFICACY OF ONC201 IN PATIENTS WITH ONC201 FOR RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA Free

PDF
Isabel Arrillaga-Romany and others
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Pages ii50–ii51, https://doi.org/10.1093/neuonc/noaa215.204
Published: 09 November 2020
Journal Article

EPID-02. SURVIVAL BENEFIT OF GLIOBLASTOMA PATIENTS AFTER FDA APPROVAL OF BEVACIZUMAB, A POPULATION-BASED STUDY USING SEER, TCR, AND NCDB DATABASES Free

PDF
Ping Zhu and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi69, https://doi.org/10.1093/neuonc/nox168.280
Published: 06 November 2017
Journal Article

NIMG-24. PATHOLOGY CONFIRMED RADIOGRAPHIC DIAGNOSIS OF TRUE PROGRESSION AND PSEUDO-PROGRESSION MADE BY ADVANCED BRAIN TUMOR IMAGING Free

PDF
Raul F Valenzuela and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi147, https://doi.org/10.1093/neuonc/nox168.600
Published: 06 November 2017
Journal Article

PATH-31. ELEVATION OF YKL-40, NORMALIZED TO CERULOPLASMIN, IN CEREBROSPINAL FLUID IS ASSOCIATED WITH GLIOBLASTOMA RECURRENCE Free

PDF
Guangrong Lu and others
Neuro-Oncology, Volume 19, Issue suppl_6, November 2017, Page vi177, https://doi.org/10.1093/neuonc/nox168.721
Published: 06 November 2017
Journal Article

DRES-08. METFORMIN OVERCOMES TEMOZOLOMIDE RESISTANCE OF GLIOMA CELLS BY MODULATING THE SOX2 PATHWAY Free

PDF
Seung Ho Yang and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi53, https://doi.org/10.1093/neuonc/now212.218
Published: 07 November 2016
Journal Article

PDCT-16. SURVIVAL BENEFIT WITH TRIPLE CHEMOTHERAPY AND TTFIELDS FOR GLIOBLASTOMA Free

PDF
Guangrong Lu and others
Neuro-Oncology, Volume 18, Issue suppl_6, November 2016, Page vi149, https://doi.org/10.1093/neuonc/now212.620
Published: 07 November 2016
Journal Article

MPTH-19PHOSPHOLIPASE C BETA 1: A CANDIDATE SIGNATURE GENE FOR PRONEURAL SUBTYPE HIGH-GRADE GLIOMA Free

PDF
Guangrong Lu and others
Neuro-Oncology, Volume 17, Issue suppl_5, November 2015, Page v142, https://doi.org/10.1093/neuonc/nov222.19
Published: 09 November 2015